Unique structural solution from a V


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 01 2021
Historique:
received: 19 05 2020
accepted: 10 12 2020
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 9 2 2021
Statut: epublish

Résumé

Broadly neutralizing antibodies (bnAbs) targeting conserved influenza A virus (IAV) hemagglutinin (HA) epitopes can provide valuable information for accelerating universal vaccine designs. Here, we report structural details for heterosubtypic recognition of HA from circulating and emerging IAVs by the human antibody 3I14. Somatic hypermutations play a critical role in shaping the HCDR3, which alone and uniquely among V

Identifiants

pubmed: 33495478
doi: 10.1038/s41467-020-20879-6
pii: 10.1038/s41467-020-20879-6
pmc: PMC7835374
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Epitopes 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

559

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI121285
Pays : United States
Organisme : NIH HHS
ID : S10 OD012289
Pays : United States

Références

PLoS Med. 2007 May;4(5):e178
pubmed: 17535101
Science. 2013 May 10;340(6133):711-6
pubmed: 23539181
Nat Commun. 2016 Sep 13;7:12780
pubmed: 27619409
Science. 2009 Apr 10;324(5924):246-51
pubmed: 19251591
Nat Rev Immunol. 2006 Aug;6(8):573-83
pubmed: 16868548
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
Blood. 1994 Jan 15;83(2):435-45
pubmed: 7506951
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Cell Host Microbe. 2015 Oct 14;18(4):395-7
pubmed: 26468743
Lancet. 2014 Feb 22;383(9918):714-21
pubmed: 24507376
Immunity. 2018 Jan 16;48(1):174-184.e9
pubmed: 29343437
Nat Commun. 2015 Jul 21;6:7708
pubmed: 26196962
JAMA. 2006 Feb 22;295(8):891-4
pubmed: 16456087
Sci Rep. 2016 Mar 07;6:22666
pubmed: 26947245
Cell Rep. 2017 Apr 11;19(2):235-245
pubmed: 28402848
Lancet Respir Med. 2013 Dec;1(10):771-8
pubmed: 24461756
Viruses. 2019 Apr 30;11(5):
pubmed: 31052339
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
Cell. 2016 Jul 28;166(3):596-608
pubmed: 27453466
Nature. 2012 Sep 27;489(7417):526-32
pubmed: 22982990
Cell Rep. 2017 Sep 19;20(12):2935-2943
pubmed: 28930686
Cell. 2015 May 21;161(5):1026-1034
pubmed: 25959776
Sci Rep. 2018 Jun 5;8(1):8628
pubmed: 29872070
Science. 2006 Apr 21;312(5772):404-10
pubmed: 16543414
Emerg Infect Dis. 2007 Sep;13(9):1348-53
pubmed: 18252106
J Virol. 2013 Jun;87(12):6542-50
pubmed: 23576508
Nature. 1981 Jan 29;289(5796):373-8
pubmed: 6162101
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23
pubmed: 24927560
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Cell. 2016 Jul 28;166(3):609-623
pubmed: 27453470
J Immunol. 2019 Jan 15;202(2):368-373
pubmed: 30617118
PLoS Pathog. 2014 May 01;10(5):e1004103
pubmed: 24788925
Virol J. 2018 Jan 19;15(1):17
pubmed: 29370862
Bioinformatics. 2008 Sep 1;24(17):1953-4
pubmed: 18641403
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10275-80
pubmed: 24982157
Science. 2011 Aug 12;333(6044):850-6
pubmed: 21798894
Cell Host Microbe. 2015 Mar 11;17(3):369-376
pubmed: 25766295
Front Immunol. 2019 Jul 18;10:1677
pubmed: 31379866
J Clin Invest. 2016 Feb;126(2):605-10
pubmed: 26731473
Immunohorizons. 2019 Apr 1;3(4):133-148
pubmed: 31032479
J Virol. 2015 Mar;89(6):2990-4
pubmed: 25540375
J Virol. 2013 Jun;87(12):7149-54
pubmed: 23552413
Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
pubmed: 16855301
Cell Host Microbe. 2015 Mar 11;17(3):377-384
pubmed: 25766296
Cell Host Microbe. 2013 Jul 17;14(1):93-103
pubmed: 23870317
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Curr Opin Struct Biol. 1994 Dec;4(6):857-67
pubmed: 7536111
Nat Commun. 2016 Dec 02;7:13577
pubmed: 27910950
J Am Chem Soc. 2009 Mar 25;131(11):3794-5
pubmed: 19292479
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Infect Disord Drug Targets. 2007 Dec;7(4):318-28
pubmed: 18220963
J Clin Microbiol. 2005 Nov;43(11):5760-7
pubmed: 16272514
Science. 2017 Oct 27;358(6362):496-502
pubmed: 28971971
Immunol Rev. 2017 Jan;275(1):203-216
pubmed: 28133796
Annu Rev Biochem. 2000;69:531-69
pubmed: 10966468
Curr Opin Immunol. 2016 Oct;42:48-55
pubmed: 27268395
Front Immunol. 2019 Mar 18;10:440
pubmed: 30949165
mBio. 2013 Jul 09;4(4):
pubmed: 23839219
Cell. 2019 May 16;177(5):1136-1152.e18
pubmed: 31100268
Virol J. 2010 Mar 05;7:53
pubmed: 20202225
J Virol. 2014 Jun;88(12):7083-92
pubmed: 24719426
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Elife. 2016 Mar 21;5:
pubmed: 26997349
PLoS One. 2015 Jul 30;10(7):e0134576
pubmed: 26226046

Auteurs

Wayne D Harshbarger (WD)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Derrick Deming (D)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Gordon J Lockbaum (GJ)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.

Nattapol Attatippaholkun (N)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Maliwan Kamkaew (M)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Shurong Hou (S)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.

Mohan Somasundaran (M)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.

Jennifer P Wang (JP)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Robert W Finberg (RW)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Quan Karen Zhu (QK)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Celia A Schiffer (CA)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA. Celia.schiffer@umassmed.edu.

Wayne A Marasco (WA)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. wayne_marasco@dfci.harvard.edu.
Department of Medicine, Harvard Medical School, Boston, MA, USA. wayne_marasco@dfci.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH